BJTJ-1837, a novel FXI activation-blocking antibody
Authors:
Open Access
- 7 February 2023
- journal article
- research article
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 7 (2) , 100067
Abstract
No abstract availableKeywords
Funding Information
- Jiangsu Hengrui Medicine
This publication has 18 references indexed in Scilit:
- The dimeric structure of factor XI and zymogen activationBlood, 2013
- Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgeryThrombosis and Haemostasis, 2011
- A role for factor XIIa–mediated factor XI activation in thrombus formation in vivoBlood, 2010
- Structure and function of factor XIBlood, 2010
- Factor XI deficiency in animal modelsJournal of Thrombosis and Haemostasis, 2009
- Reduced incidence of ischemic stroke in patients with severe factor XI deficiencyBlood, 2008
- Effects of factor IX or factor XI deficiency on ferric chloride‐induced carotid artery occlusion in miceJournal of Thrombosis and Haemostasis, 2005
- High Levels of Coagulation Factor XI as a Risk Factor for Venous ThrombosisNew England Journal of Medicine, 2000
- A Binding Site for Thrombin in the Apple 1 Domain of Factor XIJournal of Biological Chemistry, 1996
- Identification and characterization of a binding site for factor XIIa in the Apple 4 domain of coagulation factor XI.Journal of Biological Chemistry, 1993